Guided Therapeutics Inc. (GTHP) Financials Nov 14, 2014, 3:56 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Guided Therapeutics Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.55M 3.36M 3.62M 3.41M 1.18M
Cost of Goods Sold (COGS) incl. D&A 7,000 7,000 140,000 478,000 1.07M
COGS excluding D&A 0 0 106,000 117,000 611,000
Depreciation & Amortization Expense 7,000 7,000 34,000 361,000 461,000
Depreciation - - - 361,000 461,000
Amortization of Intangibles - - - 0 0
Gross Income 1.54M 3.36M 3.48M 2.93M 107,000
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 3.4M 4.98M 6.62M 7.21M 6.71M
Research & Development 1.41M 1.81M 2.78M 3.23M 2.74M
Other SG&A 1.99M 3.17M 3.84M 3.99M 3.97M
Other Operating Expense 0 0 0 0 0
Unusual Expense 401,000 0 3.62M 0 674,000
EBIT after Unusual Expense (401,000) 0 (3.62M) 0 (674,000)
Non Operating Income/Expense 32,000 2,000 192,000 0 110,000
Non-Operating Interest Income 0 0 0 0 0
Equity in Affiliates (Pretax) 0 - 0 - 0
Interest Expense 3.98M 1.23M 80,000 72,000 45,000
Gross Interest Expense 3.98M 1.23M 80,000 72,000 45,000
Interest Capitalized - - 0 0 0
Pretax Income (6.21M) (2.85M) (6.64M) (4.35M) (7.22M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (6.21M) (2.85M) (6.64M) (4.35M) (7.22M)
Minority Interest Expense 0 0 0 0 0
Net Income (6.21M) (2.85M) (6.64M) (4.35M) (7.22M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (6.21M) (2.85M) (6.64M) (4.35M) (7.22M)
Preferred Dividends 223,000 1.7M 0 0 3.18M
Net Income Available to Common (6.44M) (4.55M) (6.64M) (4.35M) (10.39M)
EPS (Basic) (0.38) (0.12) (0.14) (0.08) (0.16)
Basic Shares Outstanding 16.83M 38.6M 48.87M 57.43M 65.88M
EPS (Diluted) (0.38) (0.12) (0.14) (0.08) (0.16)
Diluted Shares Outstanding 16.83M 38.6M 48.87M 57.43M 65.88M
EBITDA (1.85M) (1.61M) (3.1M) (3.92M) (6.15M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Guided Therapeutics Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 1.55M 3.36M 3.62M 3.41M 1.18M
Cost of Goods Sold (COGS) incl. D&A 7,000 7,000 140,000 478,000 1.07M
COGS excluding D&A 0 0 106,000 117,000 611,000
Depreciation & Amortization Expense 7,000 7,000 34,000 361,000 461,000
Depreciation - - - 361,000 461,000
Amortization of Intangibles - - - 0 0
Gross Income 1.54M 3.36M 3.48M 2.93M 107,000
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 3.4M 4.98M 6.62M 7.21M 6.71M
Research & Development 1.41M 1.81M 2.78M 3.23M 2.74M
Other SG&A 1.99M 3.17M 3.84M 3.99M 3.97M
Other Operating Expense 0 0 0 0 0
Unusual Expense 401,000 0 3.62M 0 674,000
EBIT after Unusual Expense (401,000) 0 (3.62M) 0 (674,000)
Non Operating Income/Expense 32,000 2,000 192,000 0 110,000
Non-Operating Interest Income 0 0 0 0 0
Equity in Affiliates (Pretax) 0 - 0 - 0
Interest Expense 3.98M 1.23M 80,000 72,000 45,000
Gross Interest Expense 3.98M 1.23M 80,000 72,000 45,000
Interest Capitalized - - 0 0 0
Pretax Income (6.21M) (2.85M) (6.64M) (4.35M) (7.22M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (6.21M) (2.85M) (6.64M) (4.35M) (7.22M)
Minority Interest Expense 0 0 0 0 0
Net Income (6.21M) (2.85M) (6.64M) (4.35M) (7.22M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (6.21M) (2.85M) (6.64M) (4.35M) (7.22M)
Preferred Dividends 223,000 1.7M 0 0 3.18M
Net Income Available to Common (6.44M) (4.55M) (6.64M) (4.35M) (10.39M)
EPS (Basic) (0.38) (0.12) (0.14) (0.08) (0.16)
Basic Shares Outstanding 16.83M 38.6M 48.87M 57.43M 65.88M
EPS (Diluted) (0.38) (0.12) (0.14) (0.08) (0.16)
Diluted Shares Outstanding 16.83M 38.6M 48.87M 57.43M 65.88M
EBITDA (1.85M) (1.61M) (3.1M) (3.92M) (6.15M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
